Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Long-Term Debt Repayments (2016 - 2025)

iBio (IBIO) has disclosed Long-Term Debt Repayments for 9 consecutive years, with $17000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Long-Term Debt Repayments fell 60.47% to $17000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $156000.0, a 10.34% decrease, with the full-year FY2025 number at $178000.0, up 102.27% from a year prior.
  • Long-Term Debt Repayments was $17000.0 for Q4 2025 at iBio, down from $47000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $6.2 million in Q4 2022 to a low of -$348000.0 in Q2 2024.
  • A 4-year average of $742153.8 and a median of $43000.0 in 2024 define the central range for Long-Term Debt Repayments.
  • Biggest YoY gain for Long-Term Debt Repayments was 213.16% in 2024; the steepest drop was 143.77% in 2024.
  • iBio's Long-Term Debt Repayments stood at $6.2 million in 2022, then crashed by 100.61% to -$38000.0 in 2023, then soared by 213.16% to $43000.0 in 2024, then crashed by 60.47% to $17000.0 in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Long-Term Debt Repayments are $17000.0 (Q4 2025), $47000.0 (Q3 2025), and $18000.0 (Q2 2025).